Advances in pediatric antimicrobial agents development

被引：3
|
作者：
Wood, James B. [1 ]
Cravens, Lauryn B. [2 ]
Creech, C. Buddy [2 ]
机构：
[1] Indiana Univ Sch Med, Div Pediat Infect Dis, Indianapolis, IN 46202 USA
[2] Vanderbilt Univ, Sch Med, Vanderbilt Vaccine Res Program, CCC 5319 Med Ctr North,1161 21st Ave South, Nashville, TN 37232 USA
来源：
CURRENT OPINION IN PEDIATRICS | 2019年 / 31卷 / 01期
关键词：
antimicrobials; drug development; multidrug-resistant organisms; PLEUROMUTILIN ANTIBIOTIC BC-3781; ACUTE BACTERIAL SKIN; DOUBLE-BLIND; CEFTAZIDIME-AVIBACTAM; TRACT-INFECTIONS; IN-VITRO; SAFETY; CEFTAROLINE; PHASE-3; PHARMACOKINETICS;
D O I：
10.1097/MOP.0000000000000713
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
Purpose of review Rising rates of multidrug-resistant organisms has necessitated the development of novel antimicrobials. In this review, we will highlight agents that have recently received licensure and those that are in clinical development. Recent findings In recent years, development of novel antimicrobial agents has accelerated. Although most studies have targeted the adult population, studies in pediatric patients are underway. Adequately powered clinical trials are needed to establish the safety and role of these new drugs. Summary The recent development of novel antimicrobials to combat multidrug-resistant organisms is encouraging; however, more studies in the pediatric population are needed.
引用
收藏
页码：135 / 143
页数：9
相关论文
共 50 条
  • [31] Therapeutic Drug Monitoring (TDM) of Antimicrobial Agents
    Kim, Shin-Woo
    INFECTION AND CHEMOTHERAPY, 2008, 40 (03) : 133 - 139
  • [32] Pharmacokinetics and Pharmacodynamics of Antimicrobial Agents in Burn Patients
    Pruskowski, Kaitlin A.
    SURGICAL INFECTIONS, 2021, 22 (01) : 77 - 82
  • [33] Treatment of urinary tract infections in the era of antimicrobial resistance and new antimicrobial agents
    Bader, Mazen S.
    Loeb, Mark
    Leto, Daniela
    Brooks, Annie A.
    POSTGRADUATE MEDICINE, 2020, 132 (03) : 234 - 250
  • [34] A review on the development of urease inhibitors as antimicrobial agents against pathogenic bacteria
    Rego, Yuri F.
    Queiroz, Marcelo P.
    Brito, Tiago O.
    Carvalho, Priscila G.
    de Queiroz, Vagner T.
    de Fatima, Angelo
    Macedo, Fernando, Jr.
    JOURNAL OF ADVANCED RESEARCH, 2018, 13 : 69 - 100
  • [35] Recent Advances in the Development of "Curcumin Inspired" Compounds as New Therapeutic Agents
    Borosky, Gabriela L.
    Laali, Kenneth K.
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2020, 20 (15) : 1543 - 1558
  • [36] Advances in pharmacokinetic-pharmacodynamic modelling for pediatric drug development: extrapolations and exposure-response analyses
    Goulooze, Sebastiaan C.
    Vis, Peter W.
    Krekels, Elke H. J.
    Knibbe, Catherijne A. J.
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2023, 16 (12) : 1201 - 1209
  • [37] Recent Advances in the Development of Triose Phosphate Isomerase Inhibitors as Antiprotozoal Agents
    Vazquez-Jimenez, Lenci K.
    Moreno-Herrera, Antonio
    Juarez-Saldivar, Alfredo
    Gonzalez-Gonzalez, Alonzo
    Ortiz-Perez, Eyra
    Paz-Gonzalez, Alma D.
    Palos, Isidro
    Ramirez-Moreno, Esther
    Rivera, Gildardo
    CURRENT MEDICINAL CHEMISTRY, 2022, 29 (14) : 2504 - 2529
  • [38] Recent Advances on the Development of Pharmacotherapeutic Agents on the Basis of Human Serum Albumin
    Liu, Fang
    Mu, Jing
    Xing, Bengang
    CURRENT PHARMACEUTICAL DESIGN, 2015, 21 (14) : 1866 - 1888
  • [39] New Antifungal Agents in Pediatric Practice
    Das, S.
    Svaprakash, M. R.
    Chakrabarti, A.
    INDIAN PEDIATRICS, 2009, 46 (03) : 225 - 231
  • [40] Review: recent advances and future development of metal complexes as anticancer agents
    Jia, Pengpeng
    Ouyang, Ruizhuo
    Cao, Penghui
    Tong, Xiao
    Zhou, Xia
    Lei, Tian
    Zhao, Yuefeng
    Guo, Ning
    Chang, Haizhou
    Miao, Yuqing
    Zhou, Shuang
    JOURNAL OF COORDINATION CHEMISTRY, 2017, 70 (13) : 2175 - 2201
12345